Warning over online GPs as struck-off doctor discovered using loophole to prescribe ‘unsafe’ drugs – Daily Telegraph

‘The health care regulator is calling for greater powers to protect patients from online GPs after a struck-off doctor was discovered using a loophole to prescribe “unsafe” drugs.’

Full Story

Daily Telegraph, 6th August 2018

Source: www.telegraph.co.uk

Women In England ‘Illegally Taking Abortion Pills At Home’ To Avoid Having Abortions On Public Transport – Rights Info

Posted August 1st, 2018 in abortion, medicines, news by sally

‘Currently, the law states that all abortion pills must be taken in a clinic or hospital – meaning some women end up having an abortion on public transport, or while driving home.’

Full Story

Rights Info, 31st July 2018

Source: rightsinfo.org

Medicinal cannabis: how two heartbreaking cases helped change law – The Guardian

Posted July 27th, 2018 in medicines, news by sally

‘Cases of Billy Caldwell and Alfie Dingley, who have severe epilepsy, along with lobbying, prompted change.’

Full Story

The Guardian, 26th July 2018

Source: www.theguardian.com

Home Office launches review into medical use of cannabis – Home Office

Posted June 21st, 2018 in drug offences, licensing, medical treatment, medicines, press releases by tracey

‘The Home Secretary today announced a review into the scheduling of cannabis for medicinal purposes.’

Full press release

Home Office, 19th June 2018

Source: www.gov.uk/home-office

Legalising cannabis: What you need to know – BBC News

Posted June 20th, 2018 in drug offences, medicines, news by sally

‘The government has said it will review the use of medicinal cannabis, although recreational usage will still be illegal.’

Full Story

BBC News, 19th June 2018

Source: www.bbc.co.uk

Widespread blame expected from inquiry into suspicious hospital deaths – The Guardian

Posted June 20th, 2018 in doctors, elderly, hospitals, inquiries, medicines, news by sally

‘A four-year inquiry into the deaths of hundreds of elderly people who were routinely prescribed opioid drugs is expected to say that blame lies not just with the doctor involved but also those who worked with her, failed to monitor her and who failed to investigate – including the government.’

Full Story

The Guardian, 20th June 2018

Source: www.theguardian.com

Court of Protection approves administration of medication by deception – Family Law

Posted April 19th, 2018 in Court of Protection, medical ethics, medicines, news by sally

‘Private Client analysis: Alex Ruck Keene, barrister, of 39 Essex Chambers, examines the decision of the Court of Protection in Re AB [2016] EWCOP 66 to approve deceiving a person lacking mental capacity in order to administer her medication.’

Full Story

Family Law, 19th April 2018

Source: www.familylaw.co.uk

Branded medicines face new NHS cost controls – OUT-LAW.com

Posted March 14th, 2018 in health, medicines, news by sally

‘Manufacturers of branded medicines face new statutory controls on the cost of their drugs to the NHS in the UK from 1 April.’

Full Story

OUT-LAW.com, 13th March 2018

Source: www.out-law.com

Obviousness – Hospira v Cubist Appeal – NIPC Law

Posted January 25th, 2018 in appeals, intellectual property, medicines, news, patents by tracey

‘Daptomycin is an antibiotic used to treat systemic and life-threatening infections caused by multiple drug resistant bacteria. Its effectiveness depends on its purity. The invention for which the patent in suit was granted was a way of purifying the antibiotic. In Hospira UK Ltd v Cubist Pharmaceuticals LLC [2016] EWHC 1285 (Pat) (10 June 2016), Hospira UK Ltd, (a British subsidiary of Pfizer) sought the revocation of that patent. Mr Justice Henry Carr found that the patent was invalid and ordered its revocation. Cubist Pharmaceuticals LLC (a subsidiary of Merck & Co.) appealed against that judgment and order in Hospira UK Ltd v Cubist Pharmaceuticals LLC [2018] EWCA Civ 12 (18 Jan 2018).’

Full Story

NIPC Law, 24th January 2018

Source: nipclaw.blogspot.co.uk

Legal threat to NHS plans for cheap treatment to prevent blindness – Daily Telegraph

Posted November 1st, 2017 in licensing, medicines, news by sally

‘Two drug giants are threatening to take the NHS to court for plans to offer patients cheap treatment to prevent blindness.’

Full Story

Daily Telegraph, 1st November 2017

Source: www.telegraph.co.uk

Illegal tongue splitting procedures exposed – BBC News

Posted October 9th, 2017 in cosmetic surgery, licensing, London, medicines, news by sally

‘Body modification artists have been exposed carrying out illegal and potentially dangerous tongue splitting procedures.’

Full Story

BBC News, 9th October 2017

Source: www.bbc.co.uk

Medical experts ‘complicit’ over epilepsy drug which caused deformities – Daily Telegraph

Posted September 27th, 2017 in disabled persons, health, medicines, news, pregnancy by tracey

‘Medical experts were “complicit” in allowing thousands of children to suffer deformity after resisting warnings on epilepsy drugs, campaigners have said.’

Full Story

Daily Telegraph, 26th September 2017

Source: www.telegraph.co.uk

Laughing gas ban: Judge rules ‘hippy crack’ still legal despite law which bans psychoactive substances – The Independent

Posted August 31st, 2017 in drug offences, medicines, news by tracey

‘Laughing gas could still be legal after a judge dismissed a case, saying the drug is not covered by a law which bans “legal highs”.’

Full Story

The Independent, 31st August 2017

Source: www.independent.co.uk

Law Pod UK Ep. 9: Measuring clinical effectiveness for specialist drugs – 1COR

Posted August 18th, 2017 in children, medicines, news, podcasts by sally

‘Rosalind English discusses with David Hart QC a recent challenge to the refusal by the NHS to fund a specialist drug for a child suffering from a metabolic condition.’

Full Story

Law Pod UK, 17th August 2017

Source: audioboom.com

PKU funding battle: Family wins High Court challenge over drug – BBC News

Posted August 9th, 2017 in autism, children, judicial review, medicines, news by sally

‘The family of a seven-year-old boy whose condition could cause brain damage have won a High Court challenge over an NHS decision not to fund a life-changing drug.’

Full Story

BBC News, 8th August 2017

Source: www.bbc.co.uk

The Supreme Court’s Judgment in Eli Lilly v Actavis UK Ltd and Others: how to understand it and why it is important – NIPC Law

Posted July 14th, 2017 in cancer, competition, medicines, news, patents, Supreme Court by tracey

‘Supreme Court (Lords Neuberger, Mance, Clarke, Sumption and Hodge) Eli Lilly v Actavis UK Ltd and others [2017] UKSC 48 (12 July 2017)

What the Appeal was about
The pharmaceutical company Eli Lilly and Co (“Lilly”) has developed a drug called pemetrexed which it markets under the brand name Alimta for the treatment of various types of cancer. Used on its own, pemetrexed has unpleasant side effects that can sometimes be fatal but these can be avoided when it is administered as a compound called pemetrexed disodium in combination with vitamin B12.’

Full Story

NIPC Law, 13th July 2017

Source: nipclaw.blogspot.co.uk

Big pharma sues drugs watchdog over medicines price cap – Daily Telegraph

Posted July 11th, 2017 in competition, health, medicines, news by sally

‘British pharmaceutical companies are suing the NHS’s drugs watchdog in an effort to prevent drug rationing.’

Full Story

Daily Telegraph, 10th July 2017

Source: www.telegraph.co.uk

Inquest touching on the death of BT – Park Square Barristers

Posted July 5th, 2017 in coroners, inquests, medicines, news by sally

‘BT was found deceased by her partner and carer, S, on the morning of 5th June 2016.

She had an extremely complicated medical history that included diabetes, obstructive sleep apnoea, schizoaffective disorder and dissociative disorder, epilepsy, migraines and asthma.’

Full Story

Park Square Barristers, 27th June 2017

Source: www.parksquarebarristers.co.uk

‘Excessive pricing’ and pharmaceuticals – Law Society’s Gazette

Posted June 12th, 2017 in competition, markets, medicines, news, price fixing by sally

‘After years of limited focus on ‘excessive pricing’, in December 2016 the Competition and Markets Authority (CMA) took one decision finding that such an abuse of dominance had occurred, and issued a statement of objections in another case. Does this reflect a broad policy shift, or a reaction to specific cases of perceived opportunistic behaviour?’

Full Story

Law Society's Gazette, 12th June 2017

Source: www.lawgazette.co.uk

Drug company’s use of trade mark rights to restrict rival imports legitimate, rules Court of Appeal – OUT-LAW.com

Posted April 7th, 2017 in medicines, news, trade marks by tracey

‘A drug company was entitled to rely on its trade mark rights to stop two businesses from importing into the UK the same product as it sold on the basis that the rivals’ product would be sold under the drug company’s name, the Court of Appeal in London has ruled.’

Full story

OUT-LAW.com, 6th April

Source: www.out-law.com